N/A
N=52
Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM
Obstructed Defecation Syndrome · Rectocele · Intussusception · SNS
Bottom Line
View on ClinicalTrials.gov: NCT00673400 ↗Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Oct 2012
Primary outcome: Primary: Quality of Life — 3.2; 3.7; 2.8; 3.3 units on a scale — p=0.1340
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Stapled transanal rectum resection (Procedure)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Cantonal Hospital of St. Gallen
- Primary completion
- Nov 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Life |
3.2; 3.7; 2.8; 3.3; 3.3; 3.9 | 0.1340 |
| SECONDARY Morbidity |
6; 1; 2; 2; 1 | — |
| SECONDARY Hospitalization |
5 | — |
Summary
The stapled transanal rectal resection (STARR procedure) is an effective treatment for obstructed defecation syndrome (ODS) caused by intussusception and rectocele. Recently a new technique has been developed using the new Contour® TranstarTM stapler, which was specifically designed to facilitate the STARR procedure. The investigators would like to evaluate the morbidity and quality of life.
Eligibility Criteria
Inclusion Criteria
- Rectocele
- Intussusception
Exclusion Criteria
- Non operability
- inflammatory bowel disease
Data sourced from ClinicalTrials.gov (NCT00673400). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.